4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001774690-26-000006
Chief Financial Officer sold 4,578 shares at an average $32.14 ($147,145)
From the SEC's structured data for this filing
Trades in this filing
Leggett Thomas · Chief Financial Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-17 | Sale : show line 1 in the form | −1,274 | $32.74 | $41,710 | 13,476 | D |
| 2026-03-17 | Sale : show line 2 in the form | −922 | $33.38 | $30,772 | 12,554 | D |
| 2026-03-18 | Sale : show line 3 in the form | −2,173 | $31.28 | $67,980 | 10,381 | D |
| 2026-03-18 | Sale : show line 4 in the form | −172 | $31.79 | $5,468 | 10,209 | D |
| 2026-03-18 | Sale : show line 5 in the form | −37 | $32.85 | $1,215 | 10,172 | D |
| Open-market sales · 4,578 sh · avg $32.14 · $147,145 | ||||||
Loading xslF345X06/form4-03192026_100335.xml…